|
AEVIS VICTORIA SA / Key word(s): 9 Month figures Ad hoc announcement pursuant to Art. 53 LR Fribourg, 3 November 2022 AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million Organic growth accelerated to 15.2%, driven by the hotel business AEVIS VICTORIA SA (AEVIS) reports a 35.5% increase in consolidated revenues to CHF 831.0 million for the first nine months of 2022 (2021: CHF 613.1 million). AEVIS’ two main divisions, Swiss Medical Network and Victoria-Jungfrau, have continued their strong performance during the 3rd quarter, bringing the like-for-like organic growth to 15.2%. The hospitality division (Victoria-Jungfrau) continued and accelerated its performance with revenues of CHF 121.8 million (2021: CHF 82.6 million), representing a growth of 47.4%. This increase is essentially organic, as the situation on the pandemic front has normalized. The MICE (meetings, incentives, congresses and events) business is gradually picking up, despite the notable absence of Chinese customers. The promising booking levels for the year-end should enable Victoria-Jungfrau to achieve a record financial year in 2022. Swiss Medical Network increased its revenues by 26.6% to CHF 652.4 million (2021: CHF 515.3 million), including an organic growth of 3.7%. The 3rd quarter includes the traditionally weaker summer months and business is expected to accelerate in the last quarter of the year. Swiss Medical Network is continuing its development and transformation into an integrated healthcare organization. A first step has been taken in the Jura Arc, with the creation of Switzerland's first integrated healthcare organization around the Hôpital du Jura Bernois, in partnership with Visana and the Canton of Bern. AEVIS' two largest participations continue to perform well in 4Q2022 and AEVIS expects its revenues to exceed CHF 1 billion for the first time in its history. In line with the Group's investment activity, the current investment portfolio is expected to generate significant dividends and capital gains at the holding level in fiscal 2022, which should allow for a continuation and intensification of the ordinary dividend policy in 2023. For further information: AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich AEVIS VICTORIA SA - Investing for a better life AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA (90%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, Victoria-Jungfrau AG, a luxury hotel group managing ten luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com. End of Inside Information |
1477887 03-Nov-2022 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
Special
